ZA919290B - Composition containing antihistamine h2 receptor antagonists and bioadhesive material - Google Patents

Composition containing antihistamine h2 receptor antagonists and bioadhesive material

Info

Publication number
ZA919290B
ZA919290B ZA919290A ZA919290A ZA919290B ZA 919290 B ZA919290 B ZA 919290B ZA 919290 A ZA919290 A ZA 919290A ZA 919290 A ZA919290 A ZA 919290A ZA 919290 B ZA919290 B ZA 919290B
Authority
ZA
South Africa
Prior art keywords
composition containing
receptor antagonists
bioadhesive material
antihistamine
containing antihistamine
Prior art date
Application number
ZA919290A
Inventor
Adrian Francis Davis
Francis Davis Adrian
Mark Coke
Coke Mark
John Edward O'mullane
Edward O'mullane John
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA919290B publication Critical patent/ZA919290B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA919290A 1990-11-27 1991-11-25 Composition containing antihistamine h2 receptor antagonists and bioadhesive material ZA919290B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909025710A GB9025710D0 (en) 1990-11-27 1990-11-27 Novel treatment

Publications (1)

Publication Number Publication Date
ZA919290B true ZA919290B (en) 1992-09-30

Family

ID=10686017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919290A ZA919290B (en) 1990-11-27 1991-11-25 Composition containing antihistamine h2 receptor antagonists and bioadhesive material

Country Status (9)

Country Link
EP (1) EP0559812A1 (en)
JP (1) JPH06502855A (en)
AU (1) AU659422B2 (en)
CA (1) CA2096962A1 (en)
GB (1) GB9025710D0 (en)
IE (1) IE914091A1 (en)
PL (1) PL168421B1 (en)
WO (1) WO1992009286A1 (en)
ZA (1) ZA919290B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (en) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Prodn. of bio-adhesive medicament, e.g. oral or vaginal tablet - comprises mixing drug with swellable, bio-adhesive polymer, dispersant and opt. binder
WO1995001784A1 (en) * 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-sucralfate-antiflatulent combinations
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
GB9407235D0 (en) * 1994-04-12 1994-06-08 Glaxo Group Ltd Pharmaceutical compositions
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
TR199701092T1 (en) * 1995-04-03 1998-01-21 Chugai Seiyaku Kabushiki Kaisha Et Al Pharmacotic compositions containing sucralfate.
WO1997028823A1 (en) * 1996-02-08 1997-08-14 Chugai Seiyaku Kabushiki Kaisha Method of using antacid agent and pharmaceutical preparation containing antacid agent
AU2957799A (en) * 1998-04-01 1999-10-18 Chugai Seiyaku Kabushiki Kaisha Preventives for alcoholic gastritis
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
WO2023218480A1 (en) * 2022-05-09 2023-11-16 Syri Research Private Limited Liquid oral formulation of famotidine or pharmaceutically acceptable salt thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710462A1 (en) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF DISEASES OF THE gastrointestinal tract
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production

Also Published As

Publication number Publication date
IE914091A1 (en) 1992-06-03
CA2096962A1 (en) 1992-05-28
EP0559812A1 (en) 1993-09-15
WO1992009286A1 (en) 1992-06-11
AU659422B2 (en) 1995-05-18
GB9025710D0 (en) 1991-01-09
AU8909891A (en) 1992-06-25
JPH06502855A (en) 1994-03-31
PL168421B1 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
IL99539A0 (en) Fibrinogen receptor antagonists and pharmaceutical compositions containing them
GB9020051D0 (en) Muscarinic receptor antagonists
IL118476A0 (en) Hepatocyte growth factor receptor antagonists and uses thereof
OA09921A (en) Endothelin receptor antagonists
ZA948541B (en) Endothelin receptor antagonists
HU9700410D0 (en) Cosmetic composition containing a neuropeptide y receptor antagonist
AU5873594A (en) Endothelin receptor antagonists
IL118325A0 (en) Integrin receptor antagonists and pharmaceutical compositions containing them
AU3665793A (en) Fibrinogen receptor antagonists
GB9405317D0 (en) Fibrinogen receptor antagonists
AU4679793A (en) Endothelin receptor antagonists
IL109443A0 (en) Endothelin receptor antagonists
HU9502028D0 (en) Fibrinogen receptor antagonists
ZA919290B (en) Composition containing antihistamine h2 receptor antagonists and bioadhesive material
IL123832A0 (en) Multi-functional hematopoietic receptor antagonists
AU5322994A (en) Fibrinogen receptor antagonists
EP0553260A4 (en) Substantially pure interleukin-9 receptor and uses thereof
GB9320799D0 (en) Fibrinogen receptor antagonists
GB2261683B (en) Plate roofing material
EP0711157A4 (en) Endothelin receptor antagonists
ZA917693B (en) Fibrinogen receptor antagonists
IE891742L (en) Ó-adrenergic receptor antagonists
IE891741L (en) Ó-adrenergic receptor antagonists
CS294891A3 (en) Fibrinogen receptor antagonists